Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 0.8700
0.00 (0.00%)
Jun 24, 2026, 8:01 AM CET
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of €762.97 thousand as of June 24, 2026. Its market cap has decreased by -1.13% in one year.
Market Cap
762.97K
Enterprise Value
11.73M
Revenue
24.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.87
Market Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 52.02M to 762.97K, a decrease of -98.53%. That is a compound annual growth rate of -30.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 762.97K | -3.33% |
| Dec 30, 2025 | 789.25K | -19.48% |
| Dec 30, 2024 | 980.17K | -38.24% |
| Dec 29, 2023 | 1.59M | -76.50% |
| Dec 30, 2022 | 6.75M | -17.48% |
| Dec 30, 2021 | 8.18M | -57.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 57.78B |
| Siemens Healthineers AG | 38.19B |
| Bayer Aktiengesellschaft | 37.17B |
| Fresenius SE & Co. KGaA | 22.31B |
| aap Implantate AG | 24.06M |
| Maternus-Kliniken Aktiengesellschaft | 19.71M |
| Geratherm Medical AG | 14.68M |
| Biofrontera AG | 14.52M |